|
BALTIMORE, Md.—November 29, 2012—Multiple sclerosis (MS) is a neurologic disease with numerous complexities that affect its diagnosis and management. Although significant advances have been made in the understanding of MS, treatment remains challenging.
To help healthcare professionals understand how to appropriately integrate the latest clinical evidence in MS into treatment decisions, Med-IQ, an ACCME-accredited provider of continuing medical education (CME), developed an interactive, certified CME/CE activity that reviews current guideline recommendations, evidence-based treatment options, and the changing science and future perspectives in the management of MS.
 The Evolving Therapeutic Landscape in MS: Insight From the Experts
Through the presentation of a comprehensive patient case, expert faculty discuss the rationale for initiating early and uninterrupted treatment with disease-modifying therapy, strategies for identifying appropriate candidates and individualizing their treatment according to current evidence, and the importance of monitoring for and responding to a suboptimal response.
“This certified CME/CE Webcast is a really valuable resource to healthcare providers who may be looking to enhance their knowledge and apply the newest science to the care of their patients with MS,” said William A. Mencia, MD, CCMEP, Vice President of Education and Medical Affairs at Med-IQ. “This is a great opportunity to hear from some of the leading experts regarding strategies to individualize treatment when considering emerging agents versus existing effective therapies.”
| Faculty |
| |
Kathleen Costello, MS, ANP-BC, MSCN
Research Associate/Nurse Practitioner
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
|
|
| |
Brant J. Oliver, PhD, NP, MSN, MPH, MSCN
Assistant Professor
MGH Institute of Health Professions
Boston, MA
Nurse Practitioner in Neurology & Psychiatry
Concord Neurology Associates
Concord Hospital
Concord, NH
|
|
Interested clinicians are invited to learn more by visiting www.Med-IQ.com/a675.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses.
Provider approved by the California Board of Registered Nursing, provider number CEP 14745, for 1.25 contact hour.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.25 hours of Category I credit for completing this program.
Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
This activity is supported by an educational grant from Teva Pharmaceuticals.
For more information, call (toll-free) 866 858 7434, e-mail info@med-iq.com, or visit www.Med-IQ.com/a675.
|
About Med-IQ
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ received the Alliance for Continuing Education in the Health Professions' President’s Award (2012), Award for Outstanding CME Outcomes Assessment (2012), and William Campbell Felch Award for Outstanding Research in CME (2011). Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. We are a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives. To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.
For more information, contact: |
close
